Startups

EarliPoint Health

EarliPoint Health is the current brand of EarliTec Diagnostics, a medical device company using eye tracking and software analysis to help clinicians assess autism and associated developmental differences. Its technology originated in research at Children's Healthcare of Atlanta, Emory University and Yale University; the company describes its underlying platform as multimodal AI. EarliPoint Assessment measures visual engagement while a child watches videos. FDA clearance K253442, issued March 5, 2026, covers use as an aid to qualified clinicians assessing children aged 16 through 95 months who are at risk of autism. It is a prescription clinician tool. EarliTec announced its EarliPoint Health rebrand in October 2025. President and CEO Jamie Pagliaro began the role August 1, 2025; scientific founders include Warren Jones and Chief Clinical Officer Ami Klin. The company announced a $19.5 million Series A in February 2022 and a $21.5 million Series B in April 2024. An April 2026 SEC filing reports $3.5 million of debt sold in an ongoing $7 million offering.

Founded 2019